Centrum Słuchu i Mowy MEDINCUS
- Address
- Ul. Mokra 7, Kajetany, 05-830 Nadarzyn, Poland
Centrum Sluchu I Mowy Sp. z o.o. - Specialized Otolaryngology Research Center
Centrum Sluchu I Mowy Sp. z o.o. (Center for Hearing and Speech) is a distinguished clinical research facility specializing in otolaryngological conditions. The center demonstrates particular expertise in investigating innovative therapeutic approaches for chronic rhinosinusitis with nasal polyps and hearing disorders, conducting advanced trials evaluating novel biologics and targeted drug delivery systems.
- Chronic Rhinosinusitis with Nasal Polyps (CRSwNP) treatment studies, including evaluation of biologic therapies such as benralizumab and verekitug for eosinophilic disease
- Sudden Sensorineural Hearing Loss (ISSNHL) interventions, investigating intratympanic drug delivery alternatives to systemic corticosteroid therapy
- Complex respiratory and otologic comorbidities, including patients with severe CRSwNP and concurrent asthma
The research center utilizes sophisticated assessment methodologies including nasal endoscopy scoring, pure tone audiometry, and patient-reported outcome measures to evaluate treatment efficacy. With a focus on both upper respiratory tract inflammatory diseases and auditory disorders, the center contributes valuable data to the development of targeted therapies that aim to improve quality of life for patients suffering from debilitating ear, nose, and throat conditions.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 1 by active trials.
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
No repeated partnerships found.
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 1 624 other sites in Poland
Therapeutic Area Benchmark — Poland
Select a therapeutic area to compare against other sites in Poland.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Poland
Market Share
Country: Poland
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Centrum Słuchu i Mowy MEDINCUS
lock Showing 1 of 4 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| Efficacy and Safety Evaluation of Verekitug (UPB-101) in Chronic Rhinosinusitis with Nasal Polyps on Nasal Corticosteroids: A Randomized, Double-Blind, Placebo-Controlled Study | Upstream Bio Inc. | Phase II | Not Recruiting | Jul 2024 | Jul 2025 |
IMP list
lock Showing 1 of 6 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| 6-Fluoro-9-Methyl-9H-Pyrido[3,4-B]-Indole | 1 | Unknown | 2022-08-08 | 2022-08-08 |
Request feasibility information
Ask this centre about capacity, equipment and patient population.
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.